Evidence map›Paper›PMID 33537905›Full record

ArticleEuropean child & adolescent psychiatry2022

Acute myocardial infarction due to spontaneous coronary artery dissection in a 6-year-old boy with ADHD on the third day of treatment with methylphenidate.

Thomas Stammschulte, Martina Pitzer, Wolfgang Rascher, Michael Becker, Ulrich Pohlmann, Stefan Ostermayer, Gunter Kerst

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in European child & adolescent psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Thomas StammschulteDrug Commission of the German Medical Association, Berlin, Germany. thomas.stammschulte@akdae.de.ORCID http://orcid.org/0000-0003-3830-3843
Martina PitzerDrug Commission of the German Medical Association, Berlin, Germany.
Wolfgang RascherDrug Commission of the German Medical Association, Berlin, Germany.
Michael BeckerClinic for Cardiology, Nephrology and Internal Intensive Care Medicine, Rhein-Maas Klinikum, Würselen, Germany.
Ulrich PohlmannClinic for Pediatric and Adolescent Medicine, St. Marien Hospital, Düren, Germany.
Stefan OstermayerDepartment of Pediatric Cardiology, University Clinic Aachen, Aachen, Germany.
Gunter KerstDepartment of Pediatric Cardiology, University Clinic Aachen, Aachen, Germany.
German Medical Association · DEUniversitätsklinikum Aachen · DEKlinikum Rheine · DESt. Marien Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methylphenidate (MPH) is an indirect-acting sympathomimetic drug and structurally related to amphetamine. It is widely used to treat children aged 6 years and older, as well as adolescents who have attention-deficit/hyperactivity disorder (ADHD). We report on a 6-year-old boy who presented with typical angina symptoms occurring several hours after intake of an increased dose of MPH, which had been initiated for ADHD treatment 2 days earlier. Despite typical angina symptoms, the diagnosis of myocardial infarction due to spontaneous coronary artery dissection of the right coronary artery was delayed. Most epidemiological studies could not detect an increased risk for cardiovascular events in association with ADHD medications. However, the direct temporal relationship in our case indicates the possibility that MPH may trigger spontaneous coronary artery dissection in predisposed patients. Since myocardial infarction in children is rare but comprises various etiologies, awareness of this possible catastrophic event among medical staff may be lower and may delay immediate life-saving diagnostic and therapeutic measures.

Indexed as

Attention Deficit Disorder with HyperactivityCentral Nervous System StimulantsMethylphenidateMyocardial InfarctionChildCoronary VesselsDelayed-Action PreparationsHumansMaleTreatment OutcomeCentral Nervous System StimulantsDelayed-Action PreparationsMethylphenidateAdverse drug reactionAttention deficit hyperactivity disorderMethylphenidateMyocardial infarctionSpontaneous coronary artery dissection

Identifiers

PMID33537905
OpenAlexW3127059765

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.